IONS - Company ID 0000874015
The table below shows IONIS PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $943.71M | $705.14M | $787.65M | $587.37M | $810.46M | $729.26M |
| Cost of revenue | $15.91M | $11.21M | $9.13M | $14.12M | $10.84M | $11.95M |
| Gross profit | - | - | - | - | - | - |
| R&D | $915.62M | $901.53M | $899.63M | - | $638.20M | $531.00M |
IONIS PHARMACEUTICALS INC reported annual revenue of $943.71M for fiscal year 2025. That is up 33.8% from $705.14M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $346.62M (FY 2016) to $943.71M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $393.87M |
| $267.47M |
| $232.62M |
| $150.29M |
| $186.35M |
| $354.32M |
| Operating income | -$381.68M | -$475.08M | -$353.73M | -$410.19M | -$30.19M | -$172.08M |
| Income tax | $1.79M | -$6.17M | $32.32M | $11.74M | -$551.00K | $345.19M |
| Net income | -$381.39M | -$453.90M | -$366.29M | -$269.72M | -$28.60M | -$444.26M |
| EPS (diluted) | -$2.38 | -$3.04 | -$2.56 | -$1.90 | -$0.20 | -$3.18 |